Approval · Notice of Compliance 4972 · 1995
CANESTEN: Notice of Compliance 4972
Issued February 22, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4972
- Date
- February 22, 1995
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anti-fungal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CANESTEN | 02150832 | Cancelled Post Market |
| CANESTEN | 02150840 | Marketed |
| CANESTEN | 02150859 | Marketed |
| CANESTEN | 02150867 | Marketed |
| CANESTEN | 02150875 | Cancelled Post Market |
| CANESTEN | 02150883 | Marketed |
| CANESTEN | 02150891 | Marketed |
| CANESTEN | 02150905 | Marketed |
| CANESTEN | 02150913 | — |
| CANESTEN | 02150921 | Cancelled Post Market |
| CANESTEN | 02150948 | Cancelled Post Market |
Medicinal ingredients
- CLOTRIMAZOLE 100 MG per TAB
- CLOTRIMAZOLE 200 MG per TAB
- CLOTRIMAZOLE 500 MG per TAB
- CLOTRIMAZOLE 1 PER
- CLOTRIMAZOLE 10 PER
- CLOTRIMAZOLE 2 PER
- CLOTRIMAZOLE 100 PER
- CLOTRIMAZOLE 200 PER
- CLOTRIMAZOLE 500 PER